ERBB2 and neoplasm: In this context, the role of liquid biopsy stands out: among tumor-derived circulating biomarkers, circulating tumor cells (CTCs) can provide additional information to tissue biopsies to map tumor heterogeneity and evolution, better reflecting the HER2 status of the disease.